Panmure Liberum act as Nominated Adviser and Sole Broker to Optima Health Plc on its admission to trading on AIM
We are very pleased to have acted as Nominated Adviser and Sole Broker to Optima Health Plc on its admission to trading on AIM. The shares were admitted to trading today, 26 September 2024.
Optima Health is the UK's leading provider of occupational health and wellbeing services, serving over 2,000 public and private clients with a 10% share of the £1.2 billion UK market. Optima had adjusted EBITDA of £18m in FY24.
The Group offers a comprehensive range of flexible and progressive services from statutory driven workplace health surveillance medicals to proactive and preventive interventions, through to workplace health advice and attendance management assessments, and ultimately rehabilitation programmes and pathways aimed at returning people to work.
Panmure Liberum will be retained as Nominated Adviser and Sole Broker to Company following admission, and we are excited to support the Optima Health Board and the team as they continue to grow and develop as a public listed company.
Panmure Liberum Team
Senior Adviser – Nicholas Wells
Investment Banking – Emma Earl, Will Goode, Mark Rogers, Gaya Bhatt
Research – Julie Simmonds
Sales – David Cox, Oliver Baxendale, Oliver Houghton
CIR – Connie Owens
Corporate Broking – Rupert Dearden
